Journal
KIDNEY INTERNATIONAL
Volume 79, Issue 6, Pages 583-586Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ki.2010.517
Keywords
-
Categories
Ask authors/readers for more resources
Mostly indirect evidence suggests an important pathogenic role for non-HLA anti-endothelial cell antibodies (AECAs) in both acute and chronic rejection. The lack of standardized screening assays for AECAs unfortunately hampers the systematic collection of data in multicenter trials. Diagnostic tests based on commercially available platforms could pave the way for testing larger patient cohorts, but they still suffer from some important limitations. Kidney International (2011) 79, 583-586. doi: 10.1038/ki.2010.517
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available